Goodwin represented neuroscience company Cerevance in a $5 million extension of its Series A financing. The additional funding was provided by the Dementia Discovery Fund, an…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
